In the silent world of the deep sea, where strange creatures sweep the ocean floor, researchers have uncovered an unlikely ally in the fight against cancer: the humble sea cucumber.
Often overlooked in marine ecosystems and valued as a delicacy in some cultures, these soft-bodied echinoderms—particularly a species known as Holothuria floridana—may house powerful, naturally occurring compounds with the potential to hinder the growth and spread of certain cancers.
Scientists from the University of Mississippi, Georgetown University, and Ole Miss have identified a complex sugar molecule extracted from this species called fucosylated chondroitin sulfate.
Their findings, recently published in Glycobiology, reveal that this marine sugar inhibits an enzyme known as Sulf-2, which plays a central role in the progression of several aggressive cancers.
What sets this discovery apart is the compound’s low toxicity and minimal interference with blood coagulation, a significant improvement over existing Sulf-2 inhibitors that often carry the risk of serious side effects such as excessive bleeding. “
We believe that targeting Sulf-2 without disrupting the body’s natural balance could be a game-changer,” said Dr. Marwa Farrag, the study’s lead researcher. Her team utilized a blend of biochemical assays, mass spectrometry, and computer modeling to confirm the sugar’s unique biological activity.
The biological “sugar code” coating human cells is like a dense forest—enzymes like Sulf-2 act as molecular gardeners, shaping how signals travel across cellular surfaces.
When these enzymes go rogue, they can help tumors grow and spread. Blocking their activity could thus prevent cancer cells from gaining a foothold.
Beyond the standout sugar, scientists also found other potential antitumor agents in sea cucumbers, such as terpenoid glycosides and saponins—compounds already under scrutiny for their bioactive properties.
According to Professor Vitor Pomin, a pharmacognosy specialist involved in the research, “These organisms synthesize molecular structures we rarely see in land-dwelling animals. That uniqueness gives us tools we didn’t even know we needed.”
However, there’s a catch. Sea cucumbers are not only ecologically important but also increasingly rare in some regions. Their demand in cosmetics and cuisine, particularly in parts of Asia, has already raised concerns about overexploitation.
The researchers stress the importance of sustainability, noting that large-scale extraction from the ocean is not a viable option.
“We can’t just plunder the ocean floor for these animals,” Pomin explained. “Instead, we need to replicate these compounds synthetically or bioengineer them from microbial systems.
That way, we preserve marine life while making medical progress.”
The road to turning this sea cucumber sugar into an approved therapy is still long. Animal testing, clinical trials, and scalable synthesis methods are all necessary steps before patients can benefit. Still, this discovery expands the growing field of marine pharmacology—a realm where the ocean’s obscure creatures might one day hold the answers to some of humanity’s most pressing diseases.
For now, the quiet custodian of the seafloor—the sea cucumber—has offered up a clue. And science, as always, is listening.
.jpg)
.jpg)
0 Comments